New Key Statistics Module, Z-Score and F-Score
TSX:CPH Key Ratios
Market Cap C$ M | 201.58 |
Enterprise Value C$ M | 144.73 |
P/E(ttm) | 6.98 |
PE Ratio without NRI | 7.00 |
Forward PE Ratio | 11.25 |
Price/Book | 1.74 |
Price/Sales | 7.05 |
Price/Free Cash Flow | 11.42 |
Price/Owner Earnings | 12.84 |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 29.00 |
EPS (TTM) C$ | 1.20 |
Beneish M-Score | -1.53 |
10-y EBITDA Growth Rate % | -2.30 |
5-y EBITDA Growth Rate % | 20.60 |
y-y EBITDA Growth Rate % | 5.30 |
EV-to-EBIT | 10.01 |
EV-to-EBITDA | 9.02 |
PEG | 0.34 |
Shares Outstanding M | 24.11 |
Net Margin (%) | 102.51 |
Operating Margin % | 48.53 |
Pre-tax Margin (%) | 58.40 |
Quick Ratio | 7.55 |
Current Ratio | 7.96 |
ROA % (ttm) | 26.52 |
ROE % (ttm) | 29.70 |
ROIC % (ttm) | 47.82 |
Dividend Yield % | -- |
Altman Z-Score | 15.22 |
TSX:CPH Number of Guru Trades
TSX:CPH Volume of Guru Trades
Gurus Latest Trades with TSX:CPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:CPH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cipher Pharmaceuticals Inc Insider Transactions
No Available Data